Literature DB >> 15105268

Manganese-induced parkinsonism and Parkinson's disease.

C W Olanow1.   

Abstract

It has long been appreciated that manganese exposure can cause neurotoxicity and a neurologic syndrome that resembles Parkinson's disease (PD). Current evidence indicates that manganese-induced parkinsonism can be differentiated from PD because of its predilection to accumulate in and damage the pallidum and striatum rather than the SNc. The clinical syndrome, response to levodopa, imaging studies with MRI and PET, and pathologic features all help to distinguish these two conditions and permit the correct diagnosis to be established. This is of particular relevance in differentiating patients with parkinsonism due to manganese intoxication from patients with idiopathic PD who have incidental manganese exposure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105268     DOI: 10.1196/annals.1306.018

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  140 in total

1.  Manganese-induced NF-kappaB activation and nitrosative stress is decreased by estrogen in juvenile mice.

Authors:  Julie A Moreno; Karin M Streifel; Kelly A Sullivan; William H Hanneman; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2011-04-21       Impact factor: 4.849

Review 2.  The role of the Golgi-resident SPCA Ca²⁺/Mn²⁺ pump in ionic homeostasis and neural function.

Authors:  Wenfang He; Zhiping Hu
Journal:  Neurochem Res       Date:  2011-11-15       Impact factor: 3.996

Review 3.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

4.  Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems.

Authors:  Allison W Willis; Bradley A Evanoff; Min Lian; Aiden Galarza; Andrew Wegrzyn; Mario Schootman; Brad A Racette
Journal:  Am J Epidemiol       Date:  2010-10-19       Impact factor: 4.897

Review 5.  Industrial toxicants and Parkinson's disease.

Authors:  W Michael Caudle; Thomas S Guillot; Carlos R Lazo; Gary W Miller
Journal:  Neurotoxicology       Date:  2012-01-30       Impact factor: 4.294

6.  Hypothyroidism induced by loss of the manganese efflux transporter SLC30A10 may be explained by reduced thyroxine production.

Authors:  Chunyi Liu; Steven Hutchens; Thomas Jursa; William Shawlot; Elena V Polishchuk; Roman S Polishchuk; Beth K Dray; Andrea C Gore; Michael Aschner; Donald R Smith; Somshuvra Mukhopadhyay
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

7.  Assessment of dry season surface, ground, and treated water quality in the Cape Coast municipality of Ghana.

Authors:  E K Quagraine; C K Adokoh
Journal:  Environ Monit Assess       Date:  2010-01       Impact factor: 2.513

8.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Kevin C Ess; Keith M Erikson; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-10-22       Impact factor: 4.294

9.  Manganese-enhanced MRI (MEMRI) via topical loading of Mn(2+) significantly impairs mouse visual acuity: a comparison with intravitreal injection.

Authors:  Tsen-Hsuan Lin; Chia-Wen Chiang; Kathryn Trinkaus; William M Spees; Peng Sun; Sheng-Kwei Song
Journal:  NMR Biomed       Date:  2014-01-16       Impact factor: 4.044

10.  Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.

Authors:  Zhaobao Yin; Haiyan Jiang; Eun-Sook Y Lee; Mingwei Ni; Keith M Erikson; Dejan Milatovic; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2009-12-09       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.